Somatic and germline genomics in paediatric acute lymphoblastic leukaemia (Q90463690)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546053 AND SRC:MED&resulttype=core&format=json

14 April 2020

title

Somatic and germline genomics in paediatric acute lymphoblastic leukaemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546053 AND SRC:MED&resulttype=core&format=json

14 April 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546053 AND SRC:MED&resulttype=core&format=json

14 April 2020

Jun J Yang

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546053 AND SRC:MED&resulttype=core&format=json

14 April 2020

author name string

Kim E Nichols

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546053 AND SRC:MED&resulttype=core&format=json

14 April 2020

publication date

1 April 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546053 AND SRC:MED&resulttype=core&format=json

Nature Reviews Clinical Oncology

14 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546053 AND SRC:MED&resulttype=core&format=json

14 April 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546053 AND SRC:MED&resulttype=core&format=json

14 April 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546053 AND SRC:MED&resulttype=core&format=json

14 April 2020

page(s)

227-240

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546053 AND SRC:MED&resulttype=core&format=json

Global efforts toward the cure of childhood acute lymphoblastic leukaemia

14 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

The landscape of genomic alterations across childhood cancers

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Inherited genetic variation in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Germline Mutations in Predisposition Genes in Pediatric Cancer

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Predisposition to pediatric and hematologic cancers: a moving target

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Treatment of acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Genomics in acute lymphoblastic leukaemia: insights and treatment implications

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Philadelphia Chromosome-like Acute Lymphoblastic Leukemia.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Deregulation of DUX4 and ERG in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

ETV6/RUNX1-like acute lymphoblastic leukemia: A novel B-cell precursor leukemia subtype associated with the CD27/CD44 immunophenotype.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Whole-genome noncoding sequence analysis in T-cell acute lymphoblastic leukemia identifies oncogene enhancer mutations.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Genetic Basis of Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

IKZF1plus Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Intensifying Treatment of Childhood B-Lymphoblastic Leukemia With IKZF1 Deletion Reduces Relapse and Improves Overall Survival: Results of Malaysia-Singapore ALL 2010 Study

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Outcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapy

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic l

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Genotype-Specific Minimal Residual Disease Interpretation Improves Stratification in Pediatric Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Outcome of children with hypodiploid ALL treated with risk-directed therapy based on MRD levels

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Recommendations for Surveillance for Children with Leukemia-Predisposing Conditions.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Introduction to cancer genetic susceptibility syndromes.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Genetic predisposition to hematologic malignancies: management and surveillance

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Genetic predisposition to leukemia and other hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Inherited susceptibility to pre B-ALL caused by germline transmission of PAX5 c.547G>A.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Germline ETV6 Mutations Confer Susceptibility to Acute Lymphoblastic Leukemia and Thrombocytopenia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Transcriptional control of early B cell development

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Transcriptional networks in developing and mature B cells

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Commitment to the B-lymphoid lineage depends on the transcription factor Pax5

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

https://api.crossref.org/works/10.1038/S41571-018-0136-6

1 reference

7 January 2021

IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Loss of B Cells in Patients with Heterozygous Mutations in IKAROS.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Germline IKAROS mutation associated with primary immunodeficiency that progressed to T-cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

ATM and the Molecular Pathogenesis of Ataxia Telangiectasia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia: a report from the French national registry of primary immune deficiencies

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Malignancies in pediatric patients with ataxia telangiectasia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Parotid and thyroid gland cancers in patients with ataxia-telangiectasia.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Incidence of cancer in 161 families affected by ataxia-telangiectasia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

A single ataxia telangiectasia gene with a product similar to PI-3 kinase

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Dysregulated TCL1 promotes multiple classes of mature B cell lymphoma

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Expression of TCL1 in hematologic disorders

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Nijmegen breakage syndrome (NBS)

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Nijmegen Breakage Syndrome: Clinical and Immunological Features, Long-Term Outcome and Treatment Options - a Retrospective Analysis.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

TP53 Mutations in Hypodiploid Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

The genomic landscape of hypodiploid acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Clinical Management and Tumor Surveillance Recommendations of Inherited Mismatch Repair Deficiency in Childhood

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium 'care for CMMRD' (C4CMMRD).

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium “Care for CMMR-D” (C4CMMR-D)

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Acute lymphoblastic leukemia and lymphoma in the context of constitutional mismatch repair deficiency syndrome

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Comprehensive Analysis of Hypermutation in Human Cancer

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Immunotherapy holds the key to cancer treatment and prevention in constitutional mismatch repair deficiency (CMMRD) syndrome

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Ataxia-telangiectasia and acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Treatment of lymphoid malignancies in patients with ataxia-telangiectasia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Leukoencephalopathy after prophylactic radiation for leukaemia in ataxia telangiectasia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Ataxia-telangiectasia: atypical presentation and toxicity of cancer treatment.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Involvement of the DNA mismatch repair system in antineoplastic drug resistance

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Mismatch repair-dependent metabolism of O6-methylguanine-containing DNA in Xenopus laevis egg extracts.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Reduction of MLH1 and PMS2 confers temozolomide resistance and is associated with recurrence of glioblastoma

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Acquired temozolomide resistance in human glioblastoma cell line U251 is caused by mismatch repair deficiency and can be overcome by lomustine.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Carcinogen-specific induction of genetic instability.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Preclinical evaluation of NUDT15-guided thiopurine therapy and its effects on toxicity and anti-leukemic efficacy.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

The effects of inherited NUDT15 polymorphisms on thiopurine active metabolites in Japanese children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Interaction between NUDT15 and ABCC4 variants enhances intolerability of 6-mercaptopurine in Japanese patients with childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Multidrug resistance protein 4 (MRP4) polymorphisms impact the 6-mercaptopurine dose tolerance during maintenance therapy in Japanese childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Negative feedback-defective PRPS1 mutants drive thiopurine resistance in relapsed childhood ALL.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

NT5C2 germline variants alter thiopurine metabolism and are associated with acquired NT5C2 relapse mutations in childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Pathophysiology of Glucocorticoid Signaling.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Genetic predictors of glucocorticoid-induced hypertension in children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Primary epiphyseal arteriopathy in a mouse model of steroid-induced osteonecrosis

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

CREBBP mutations in relapsed acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Tumor suppressor IKZF1 mediates glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

HLA-DRB1*07:01 is associated with a higher risk of asparaginase allergies.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

HLA-DRB1*07:01-HLA-DQA1*02:01-HLA-DQB1*02:02 haplotype is associated with a high risk of asparaginase hypersensitivity in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Variants in CPA1 are strongly associated with early onset chronic pancreatitis

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Asparaginase pharmacology: challenges still to be faced

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Inhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid response

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

An Inherited Genetic Variant in CEP72 Promoter Predisposes to Vincristine-Induced Peripheral Neuropathy in Adults With Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Pediatric leukemia predisposition syndromes: clues to understanding leukemogenesis

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Bloom's syndrome. XX. The first 100 cancers

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Cancer predisposition syndromes associated with myeloid malignancy

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Down Syndrome Preleukemia and Leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Acute leukemias in children with Down syndrome

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Unique clinical and biological features of leukemia in Down syndrome children

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Epidemiology of childhood leukemia in the presence and absence of Down syndrome

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Haematological spectrum and genotype-phenotype correlations in nine unrelated families with RUNX1 mutations from the French network on inherited platelet disorders

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Familial myelodysplastic syndrome/acute leukemia syndromes: a review and utility for translational investigations

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

A 20-year perspective on the International Fanconi Anemia Registry (IFAR).

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Cancer in Fanconi anemia.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Cancer incidence in persons with Fanconi anemia.

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Fanconi anemia and the development of leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Neurofibromatosis and childhood leukaemia/lymphoma: a population-based UKCCSG study

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Bedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemia

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

RAS diseases in children

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

Acute lymphoblastic leukemia in the context of RASopathies

1 reference

https://api.crossref.org/works/10.1038/S41571-018-0136-6

7 January 2021

10.1038/S41571-018-0136-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546053 AND SRC:MED&resulttype=core&format=json

14 April 2020

1 reference